Celtic raises $156 million, drops TransMID

Investment company Celtic ( Hamilton, Bermuda) raised $156 million in a private placement of notes. The notes are secured against the seven drug development programs in Celtic's portfolio, which include Xerecept corticotropin-releasing factor (CRF). Xerecept is in Phase III testing to treat peritumoral brain edema. ...